bioRxiv and Citations: Just Another Piece of Flawed Bibliometric Research?
Even a flawed paper can offer lessons on how (not) to report, and what (not) to claim.
Even a flawed paper can offer lessons on how (not) to report, and what (not) to claim.
Major scholarly publishers have made substantial investments in preprints in recent years, integrating preprint deposit into manuscript submission workflows.
As publishers increasingly lose control of the final stage of the publishing process, they are looking elsewhere to extract economic value. They are finding it upstream, in the various linked processes that lead to the (erstwhile) final document.
Why do authors continue to cite preprints years after they’ve been formally published?
Starting today, anyone who visits the online retailer Amazon will soon be able to review manuscripts, just like pens, sneakers, and toiletry products.
A flawed article claiming that manuscripts don’t change much between being preprints and published articles somehow makes it through peer review unchanged.
By incorporating post-publication validation badges into preprints, bioRxiv begins to transform itself from a preprint server into a publishing platform.
Paying a living wage for reviews could provide postdocs with a temporary career alternative. But it won’t come cheaply and it will likely result in an uncompetitive journal with little chance of success.
Citation indexes need to provide standardized citation histograms for editors and publishers. Without them, it is unlikely that they will be widely adopted. At worse, it will encourage the production of histograms that selectively highlight or obscure the data.
After hundreds of manipulated images were detected across 40 scientific journals, the real work will be to correct the scientific record.